Related Experiment Video
Updated: Oct 30, 2025

11:10
Hyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Published on: November 16, 2011
95.0K
Transient Hyperinsulinemic Hypoglycemia Linked to PAX6 Mutation.
Jee-Min Kim1, Seul-Ki Kim1, Shin-Hee Kim1
1Department of Pediatrics, College of Medicine, Catholic University of Korea, Seoul 06591, Korea.
Medicina (Kaunas, Lithuania)
|July 2, 2021
Summary
A mutation in the paired box-6 gene (PAX6) is linked to infant hypoglycemia and prediabetes. This finding highlights PAX6
Area of Science:
- Genetics
- Endocrinology
- Developmental Biology
Background:
- Prolonged hyperinsulinemic hypoglycemia in infancy can lead to developmental issues.
- Mutations in the paired box-6 gene (PAX6) are known to cause oculogenesis and neurogenesis disorders.
- PAX6 mutations have been implicated in adult diabetes mellitus, suggesting a role in glucose homeostasis.
Observation:
- A case report details a boy with a PAX6 mutation and anophthalmia.
- The patient experienced hypoglycemic seizures starting at 5 months of age.
- A prediabetic condition was observed in the patient at 60 months of age.
Findings:
- This case provides novel evidence linking the PAX6 gene to glucose homeostasis.
- The study highlights the potential for life-threatening hypoglycemia in infants with PAX6 mutations.
- Early-onset glucose intolerance may also be encountered in individuals with PAX6-related disorders.
Implications:
- The role of PAX6 in glucose metabolism and insulin regulation warrants further investigation.
- Understanding PAX6's function could lead to improved diagnostics and management for related metabolic disorders.
- This research underscores the pleiotropic effects of PAX6, impacting both development and metabolic function.
Related Concept Videos
Hypoglycemia and Glucagon
491
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
491
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.6K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.6K
Cell Specific Gene Expression
14.4K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
14.4K
Glucose Transporters
26.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
26.3K
Insulin Secretory Vesicles
6.1K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.1K
Inborn Errors of Metabolism
401
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
401

